赛诺医疗
(688108)
| 流通市值：71.60亿 | | | 总市值：71.60亿 |
| 流通股本：4.18亿 | | | 总股本：4.18亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 304,638,498.47 | 139,735,742.82 | 525,407,851.22 | 363,854,525.58 |
| 营业总成本 | 234,886,791.58 | 110,756,427.78 | 478,178,733.38 | 348,935,582.94 |
| 其他经营收益 | | | | |
| 营业利润 | 67,295,319.3 | 30,283,429.46 | 66,804,612.57 | 31,845,195.95 |
| 利润总额 | 67,159,618.57 | 30,284,601.47 | 68,445,914.17 | 33,516,889.46 |
| 净利润 | 55,576,065.16 | 27,080,280.35 | 47,465,942.71 | 20,719,725.46 |
| 每股收益 | | | | |
| 其他综合收益 | -1,399,068.56 | -808,182.24 | -500,262.11 | 234,158.53 |
| 综合收益总额 | 54,176,996.6 | 26,272,098.11 | 46,965,680.6 | 20,953,883.99 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 570,526,567.11 | 513,630,327.15 | 520,385,181.31 | 483,972,047.89 |
| 非流动资产: | | | | |
| 非流动资产合计 | 787,315,576.85 | 813,927,749.64 | 829,283,279 | 854,837,618.42 |
| 资产总计 | 1,357,842,143.96 | 1,327,558,076.79 | 1,349,668,460.31 | 1,338,809,666.31 |
| 流动负债: | | | | |
| 流动负债合计 | 214,110,459.19 | 202,132,615.79 | 333,750,162.35 | 222,609,855.5 |
| 非流动负债: | | | | |
| 非流动负债合计 | 71,631,560.84 | 61,254,392.33 | 56,092,127.4 | 184,385,436.86 |
| 负债合计 | 285,742,020.03 | 263,387,008.12 | 389,842,289.75 | 406,995,292.36 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 997,228,871.35 | 991,931,903.16 | 927,644,872.22 | 900,750,469.58 |
| 股东权益合计 | 1,072,100,123.93 | 1,064,171,068.67 | 959,826,170.56 | 931,814,373.95 |
| 负债和股东权益合计 | 1,357,842,143.96 | 1,327,558,076.79 | 1,349,668,460.31 | 1,338,809,666.31 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 347,871,930.21 | 157,474,066.03 | 598,914,741.22 | 413,401,906.35 |
| 经营活动现金流出小计 | 253,717,060.05 | 138,744,026.01 | 437,040,393.19 | 329,427,011.08 |
| 经营活动产生的现金流量净额 | 94,154,870.16 | 18,730,040.02 | 161,874,348.03 | 83,974,895.27 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 50,096,555.56 | - | 34,300.41 | 34,352.25 |
| 投资活动现金流出小计 | 62,430,218.19 | 8,483,346.35 | 45,800,047.72 | 31,015,450.99 |
| 投资活动产生的现金流量净额 | -12,333,662.63 | -8,483,346.35 | -45,765,747.31 | -30,981,098.74 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 208,432,700 | 186,999,350 | 113,848,550 | 73,934,400 |
| 筹资活动现金流出小计 | 255,296,549.07 | 217,434,738.6 | 123,590,572.8 | 60,270,572.58 |
| 筹资活动产生的现金流量净额 | -46,863,849.07 | -30,435,388.6 | -9,742,022.8 | 13,663,827.42 |
| 汇率变动对现金及现金等价物的影响 | -1,040,589.32 | -236,435.78 | -1,635,126.9 | -634,051.61 |
| 现金及现金等价物净增加额 | 33,916,769.14 | -20,425,130.71 | 104,731,451.02 | 66,023,572.34 |
| 期末现金及现金等价物余额 | 430,322,913.1 | 375,981,013.25 | 396,406,143.96 | 357,698,265.28 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 33,916,769.14 | - | 104,731,451.02 | - |
最新报告期：2026-08-02| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 郑涛,李虹达,王在存,贺菊颖 | 0.18 | 0.26 | 0.38 | 2026-08-02 |
| 中信证券 | 宋硕,陈竹,曾令鹏 | 0.18 | 0.25 | 0.34 | 2026-06-06 |
| 中信建投 | 郑涛,李虹达,王在存,贺菊颖 | 0.18 | 0.27 | 0.38 | 2026-05-28 |